A practical reference on Intranasal delivery: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-12-19 and is reviewed periodically as new material appears.
Published work on this peptide almost always uses intranasal delivery, with drops or a spray applied to the nasal mucosa. Some animal experiments have used subcutaneous or intraperitoneal injection, and a smaller number have compared routes directly. Oral administration is not a focus of the literature, because short peptides of this size are broken down by digestive enzymes and cross intestinal barriers poorly. How much of an intranasal dose reaches the bloodstream intact in humans remains an open question.
Animal studies have examined behaviour in tests of anxiety, memory retention and stress response, and several report changes in neurotrophic or neurotransmitter-related markers. The human evidence base is much smaller, consisting mainly of short trials conducted in Russia with limited reporting in English-language journals. Sample sizes are modest and outcome measures vary between studies, so the findings are best described as preliminary. Independent replication under modern trial standards has not been widely reported.
Lyophilized selank is normally supplied as a dry powder and is considered stable for extended periods when kept cold and dry. Moisture uptake is the main practical threat, because absorbed water promotes both hydrolysis and aggregation in the solid state. Vials are usually warmed to room temperature before opening so that condensation does not form on the powder. Supplier documentation commonly specifies -20 °C for routine storage, with -80 °C used for material intended to be archived for years.
Once dissolved, the peptide is markedly less stable than the dry powder. Aqueous solutions are subject to backbone hydrolysis and to microbial growth when they are handled without sterile technique. Buffered solutions near neutral pH are common for short-term laboratory work, while acidic conditions are sometimes used to improve solubility. Analytical laboratories generally prepare working solutions fresh rather than storing them, and a residual water film left in a reopened vial can seed degradation even when the container appears dry.
| Property | Value | Notes |
|---|---|---|
| Common route | Intranasal | Also injected in some animal work |
| Solubility class | Freely soluble in water | Solid form is hygroscopic |
| Typical storage | About -20 degrees Celsius | Keep desiccated and dark |
| Purity method | Reverse-phase HPLC | Reported as area percent |
| Confirmatory method | Mass spectrometry | Verifies expected molecular mass |
Development work on the compound began in the 1980s and 1990s at the Institute of Molecular Genetics in Moscow, within the same research programme that produced the peptide Semax. Early investigators sought a tuftsin derivative with improved resistance to enzymatic breakdown and with activity in the central nervous system after peripheral administration. Most of the primary literature from this period was published in Russian, a factor that still shapes how easily the findings can be checked by outside groups.
Naming for this compound is not fully standardised in English sources. The spelling Selanc appears in some transliterations, and catalogue entries may instead list the peptide sequence itself as the identifier. Reference material sometimes groups it with other short synthetic peptides studied for behavioural effects, which can create confusion when citations are compared. Distinguishing the exact sequence from related tuftsin analogues is therefore a practical first step when reviewing any dataset or specification sheet.
Reported pharmacological effects center on reduced anxiety-like behavior in animal models and on measures of memory and learning. Proposed contributing mechanisms include modulation of GABAergic signaling, shifts in monoamine turnover, and changes in the activity of enzymes that degrade neuropeptides. Effects on the expression of genes linked to neuroplasticity have also been described. No single molecular target is widely accepted, and whether the behavioral findings arise from one pathway or several remains an open question.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was designed as a stabilized analogue of tuftsin, a naturally occurring tetrapeptide fragment derived from the immunoglobulin heavy chain. The additional Pro-Gly-Pro segment at the carboxyl terminus is intended to slow enzymatic cleavage. The compound is usually described in the literature as a synthetic peptide with anxiolytic and cognitive-related activity, a label that reflects a research context rather than an approved therapeutic category.
Most published work on selank originates from a small number of research groups in the Russian Federation. A large share of that record appears in Russian-language journals, which limits access for readers who rely on English-indexed databases. Independent replication by laboratories outside the original research network is sparse in publicly available sources. This concentration of origin and language is a frequently noted feature when the compound is summarized in broader reviews of synthetic peptides.
Vitamin K1 is made by plants, and is found in highest amounts in green leafy vegetables, being directly involved in photosynthesis. It is active as a vitamin in animals and performs the classic functions of vitamin K, including its activity in the production of blood-clotting proteins. Animals may also convert it to vitamin K2, variant MK-4. Bacteria in the gut flora can also convert K1 into K2. All forms of K2 other than MK-4 can only be produced by bacteria, which use these during anaerobic respiration. Vitamin K3 (menadione), a synthetic form of vitamin K, was used to treat vitamin K deficiency, but because it interferes with the function of glutathione, it is no longer used in this manner in human nutrition.
The Arab Center for Research and Policy Studies described it as a "blueprint for dispossession", excluding Palestinians from decision-making, imposing foreign trusteeship without consent, prioritizing Israeli security and masking genocide through profit schemes such as the Gaza Humanitarian Foundation, which has been linked to deaths at aid distribution centers.
=== Regulation of expression === EPCIP is expressed during blastocyst, fetus, and adult states of human development. It is overexpressed during some tumor states, including pancreatic, gastrointestinal, germ cell, and glioma tumors.
Sources: en.wikipedia.org
== Selectivity == By definition, "antimicrobial" refers to something detrimental to a microbe. Because the definition of a microbe (or microorganism) is very general, something that is "antimicrobial" could have a detrimental effect against a range of organisms from beneficial to harmful ones, including mammalian cells, and cell types typically associated with diseases such as bacteria, viruses, protozoans, and fungi. Selectivity refers to the ability to combat a certain type or class of organism. Depending on the application, the ability to selectively combat certain microorganisms while having little detrimental effect against others dictates the usefulness of a particular antimicrobial surface in a given context.
Non-road engines (or non-road mobile machinery in the European Union) are internal combustion engines that are used for other purposes than a motor vehicle that is used on a public roadway. The term is commonly used by regulators to classify the engines in order to control their emissions. Non-road engines are used in a wide range of applications which may include machinery and non-road vehicles. In many jurisdictions, the term non-road engine is assumed to refer to the engines that have mobility or portability, which is separated from the term stationary engine. The definition of non-road engine may explicitly exclude certain non-road vehicles such as aircraft, locomotives, and ocean-going marine vessels.
Aeroponics Anthroponics Aquaponics Digeponics Fogponics Folkewall Grow box Growroom Nutrient film technique Organoponics Passive hydroponics Plant factory Plant nutrition Plant pathology Root rot Vertical farming Xeriscaping
=== Associated conditions === Sjögren's disease is associated with a number of other medical conditions, many of which are autoimmune or rheumatic disorders, such as celiac disease, fibromyalgia, systemic lupus erythematosus (lupus), autoimmune thyroiditis, multiple sclerosis and spondyloarthropathy, and several malignancies, principally non-Hodgkin lymphoma. Sjogren's is the second most common cause of dysautonomia.
Sources: en.wikipedia.org
== Partnerships == Rose Pharma is currently funded by CAT Invest, Nordic Biotech, BML Healthcare and 123MultiNova Europe. In 2008, Rose Pharma signed an agreement with Eli Lilly and Company (Indianapolis, United States) to in-license a Lilly compound (formerly known as LY307161, now named ROSE-010), an analogue of the naturally occurring intestinal hormone GLP-1. The licensing agreement is a result of an ongoing research collaboration the two companies have participated in since 2004.
John Dalton saw this as evidence that the chemical elements combine with each other by basic units of weight. The basic units were indivisible as far as he could tell, so he concluded he had discovered the atoms that chemists and philosophers had long hypothesized. Given a ratio of 1:2:4, Dalton deduced that the formulas for the oxides of nitrogen are N2O, NO, and NO2. In 1804, Dalton explained his atomic theory to his friend and fellow chemist Thomas Thomson, who published the first full explanation in his book A System of Chemistry in 1807. Dalton's own version appeared in 1808 under the title A New System of Chemical Philosophy and adopted with word atom to refer to objects he previous called ultimate particles. This new chemical atomic theory proposed atoms with scientific properties: all atoms of an element have the same weight; atoms of different elements have different weights. No atoms are created or destroyed in chemical reactions. Dalton was able to use his concept of atoms to reproduce the then known laws of chemistry. Dalton defined an atom as being the "ultimate particle" of a chemical substance, and he used the term "compound atom" to refer to "ultimate particles" which contain two or more elements. This is inconsistent with the modern definition, wherein an atom is the basic particle of a chemical element and a molecule is an agglomeration of atoms. The term "compound atom" was confusing to some of Dalton's contemporaries as the word "atom" implies indivisibility, but he responded that if a carbon dioxide "atom" is divided, it ceases to be carbon dioxide.
=== Taxonomic history === In bacterial taxonomy, the basionym for L. d. bulgaricus was "Thermobacterium bulgaricum" Orla-Jensen 1919. The entity became Lactobacillus bulgaricus in 1973 with the work of Rugosa and Hansen, and was reclassified as a subspecies under Lactobacillus delbrueckii in 1984.
== Volume-temperature law == Regarding the volume-temperature relationship, Gay-Lussac attributed his findings to Jacques Charles because he used much of Charles's unpublished data from 1787 – hence, the law became known as Charles's law or the law of Charles and Gay-Lussac. Amontons's, Charles', and Boyle's law form the combined gas law. These three gas laws in combination with Avogadro's law can be generalized by the ideal gas law. Gay-Lussac used the formula acquired from ΔV/V = αΔT to define the rate of expansion α for gases. For air, he found a relative expansion ΔV/V = 37.50% and obtained a value of α = 37.50%/100 °C = 1/266.66 °C which indicated that the value of absolute zero was approximately 266.66 °C below 0 °C. The value of the rate of expansion α is approximately the same for all gases and this is also sometimes referred to as Gay-Lussac's law. See the introduction to this article, and Charles's law.
=== Organizations === The IOC stated, "If you want to destroy any concept of fair play and fair competition in sport, this would be a good way to do it. ... This is completely at odds with the idea and values of the Olympic Games." Sebastian Coe, president of World Athletics, said, "No one within athletics takes the Enhanced Games seriously." WADA stated that it "warns athletes and support personnel, who wish to participate in clean sport, that if they were to take part in the Enhanced Games, they would risk committing anti-doping rule violations under the World Anti-Doping Code." WADA president Witold Bańka said TEG is a "ridiculous idea" and "very dangerous", and called for all anti-doping authorities to unite in opposition to the games. World Aquatics stated, "The Enhanced Games are not a sporting competition built on universal values like honesty, fairness and equity: they are a circus, built on shortcuts". In June 2025, it announced that people involved in events like TEG would be banned from World Aquatics events. The International Federation of Sports Medicine expressed worry that TEG would exploit young people. The Australian Olympic Committee called the idea "dangerous and irresponsible." The CEO of Sports Medicine Australia said that no member of the organization had expressed support for TEG in their capacity as healthcare professionals. The CEO of the Australian Sports Commission said, "I cannot see any responsible and ethical person thinking the Enhanced Games is even remotely sensible".
Sources: en.wikipedia.org
Most published work uses intranasal application, either as drops or as a nasal spray. Injection routes appear in a smaller set of animal experiments. Oral use is uncommon in the literature because peptide breakdown and poor absorption limit this route.
Reported human trials are few, brief and originate mainly from one country. They describe effects on anxiety-related measures, but sample sizes are small and reporting is limited. The results are widely regarded as preliminary rather than confirmed.
Reverse-phase liquid chromatography is used to assess purity and separation of related impurities. Mass spectrometry confirms that the observed molecular mass matches the expected peptide. A certificate of analysis from the supplier is the usual document of record.
Sealed, desiccated storage at -20 °C or colder is the standard recommendation for research-grade material. Vials should reach room temperature before they are opened, which limits condensation. Repeated temperature cycling is discouraged.